Financial Supplement FY 2024 - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Reinsurance
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Reinsurance RSS Get our newsletter
Order Prints
January 28, 2025 Reinsurance
Share
Share
Tweet
Email

Financial Supplement FY 2024

U.S. Markets via PUBT

RenaissanceRe Holdings Ltd.

Contents

Page

Basis of Presentation

i

Financial Highlights

1

Summary Consolidated Financial Statements

a.

Consolidated Statements of Operations

3

b.

Consolidated Balance Sheets

4

Underwriting and Reserves

a.

Consolidated Segment Underwriting Results

5

b.

Consolidated and Segment Underwriting Results - Five Quarter Trend

7

c.

Property Segment - Catastrophe and Other Property Underwriting Results

10

d.

Gross Premiums Written

12

e.

Net Premiums Written

13

f.

Net Premiums Earned

14

g.

Reserves for Claims and Claim Expenses

15

h.

Paid to Incurred Analysis

16

Managed Joint Ventures and Fee Income

a. Fee Income

17

b.

Fee income - Five Quarter Trend

18

c.

Noncontrolling Interests

19

d.

DaVinciRe Holdings Ltd. and Subsidiary Consolidated Statements of Operations

21

Investments

a.

Total Investment Result

22

b.

Investments Composition

24

c.

Managed Investments - Credit Rating

25

d.

Retained Investments - Credit Rating

26

Other Items

a.

Earnings per Share

27

Comments on Non-GAAP Financial Measures

28

RenaissanceRe Holdings Ltd.

Basis of Presentation

RenaissanceRe Holdings Ltd. (the "Company" or "RenaissanceRe") is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, the Company has offices in Bermuda, Australia, Canada, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

On November 1, 2023, the Company completed its acquisition (the "Validus Acquisition") of Validus Holdings, Ltd. ("Validus Holdings"), Validus Specialty, LLC ("Validus Specialty") and the renewal rights, records and customer relationships of the assumed treaty reinsurance business of Talbot Underwriting Limited from subsidiaries of American International Group, Inc. Validus Holdings, Validus Specialty, and their respective subsidiaries collectively are referred to herein as "Validus." The operating activities of Validus are included in the Company's consolidated statements of operations starting from the acquisition date, November 1, 2023. As such, the results of operations and comparisons to prior periods should be viewed in that context.

This financial supplement includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP") including "operating income (loss) available (attributable) to RenaissanceRe common shareholders," "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted," "operating retuon average common equity - annualized," "tangible book value per common share," "tangible book value per common share plus accumulated dividends," "adjusted combined ratio," "retained total investment result," "retained investments, at fair value," "retained investments, unrealized gain (loss)" and "operating (income) loss attributable to redeemable noncontrolling interests." A reconciliation of such measures to the most comparable GAAP figures is presented in the attached supplemental financial data. See pages 28 through 38 for "Comments on Non-GAAP Financial Measures."

All information contained herein is unaudited. Unless otherwise noted, amounts are in thousands of United States Dollars, except for share and per share amounts and ratio information. Certain prior period comparatives have been reclassified to conform to the current presentation. This supplement is being provided for informational purposes only. It should be read in conjunction with documents filed by RenaissanceRe with the U.S. Securities and Exchange Commission, including its Annual Reports on Form 10- K and its Quarterly Reports on Form 10-Q. Please refer to the Company's website at www.renre.comfor further information about RenaissanceRe.

i

Cautionary Statement Regarding Forward-Looking Statements

Any forward-looking statements made in this Financial Supplement reflect RenaissanceRe's current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company may also make forward-looking statements with respect to its business and industry, such as those relating to its strategy and management objectives, plans and expectations regarding its response and ability to adapt to changing economic conditions, market standing and product volumes, competition in the industry, and estimates of net negative impact and insured losses from loss events, and government initiatives and regulatory matters affecting the (re)insurance industries, among other things. These statements are subject to numerous factors that could cause actual results to differ materially from those addressed by such forward-looking statements, including the following: the Company's exposure to natural and non-natural catastrophic events and circumstances and the variance they may cause in the Company's financial results; the effect of climate change on the Company's business, including the trend towards increasingly frequent and severe climate events; the effectiveness of the Company's claims and claim expense reserving process; the effect of emerging claims and coverage issues; the performance of the Company's investment portfolio and financial market volatility; the effects of inflation; the Company's exposure to ceding companies and delegated authority counterparties and the risks they underwrite; the Company's ability to maintain its financial strength ratings; the Company's reliance on a small number of brokers; the highly competitive nature of the Company's industry; the historically cyclical nature of the (re)insurance industries; collection on claimed retrocessional coverage and new retrocessional reinsurance being available; the Company's ability to attract and retain key executives and employees; the Company's ability to successfully implement its business strategies and initiatives; the Company's exposure to credit loss from counterparties; the Company's need to make many estimates and judgments in the preparation of its financial statements; the Company's exposure to risks associated with its management of capital on behalf of investors; changes to the accounting rules and regulatory systems applicable to the Company's business, including changes in Bermuda and U.S. laws or regulations; the effect of current or future macroeconomic or geopolitical events or trends, including the ongoing conflicts between Russia and Ukraine, and in the Middle East; other political, regulatory or industry initiatives adversely impacting the Company; the impact of cybersecurity risks, including technology breaches or failure; the Company's ability to comply with covenants in its debt agreements; the effect of adverse economic factors, including changes in the prevailing interest rates; the effects of new or possible future tax actions or reform legislation and regulations in the jurisdictions in which the Company operates; the Company's ability to determine any impairments taken on its investments; the Company's ability to raise capital on acceptable terms; the Company's ability to comply with applicable sanctions and foreign corrupt practices laws; the Company's dependence on capital distributions from its subsidiaries; and other factors affecting future results disclosed in RenaissanceRe's filings with the SEC, including its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

ii

RenaissanceRe Holdings Ltd.

Financial Highlights

Three months ended

Year ended

December 31,

December 31,

December 31,

December 31,

2024

2023

2024

2023

Net income (loss) available (attributable) to RenaissanceRe common shareholders

$

(198,503)

$

1,576,682

$ 1,834,985

$ 2,525,757

Operating income (loss) available (attributable) to RenaissanceRe common shareholders (1)

$

406,877

$

623,110

$ 2,234,426

$ 1,824,910

Underwriting income

Gross premiums written

$

1,916,751

$

1,802,041

$11,733,066

$ 8,862,366

Net premiums written

1,751,628

1,587,047

9,952,216

7,467,813

Net premiums earned

2,527,566

2,249,445

10,095,760

7,471,133

Underwriting income (loss)

208,550

540,970

1,622,324

1,647,408

Net claims and claim expense ratio:

Current accident year

72.7 %

50.5 %

61.3 %

53.9 %

Prior accident years

(14.0)%

(7.0)%

(8.5)%

(6.1)%

Calendar year

58.7 %

43.5 %

52.8 %

47.8 %

Acquisition expense ratio

26.8 %

26.5 %

26.2 %

25.1 %

Operating expense ratio

6.2 %

6.0 %

4.9 %

5.0 %

Combined ratio

91.7 %

76.0 %

83.9 %

77.9 %

Adjusted combined ratio (1)

89.4 %

73.6 %

81.5 %

77.1 %

Fee income

Management fee income

$

53,536

$

47,769

$

219,860

$

176,599

Performance fee income

23,568

23,014

106,936

60,195

Total fee income

$

77,104

$

70,783

$

326,796

$

236,794

Investment results - managed

Net investment income

$

428,810

$

376,962

$

1,654,289

$

1,253,110

Net realized and unrealized gains (losses) on investments

(630,347)

585,939

(27,840)

414,522

Total investment result

$

(201,537)

$

962,901

$

1,626,449

$

1,667,632

Total investment retu- annualized

(2.4)%

15.2 %

5.4 %

6.9 %

Investment results - retained (1)

Net investment income

$

295,237

$

256,445

$

1,138,028

$

830,533

Net realized and unrealized gains (losses) on investments

(552,332)

490,387

(41,863)

285,765

Total investment result

$

(257,095)

$

746,832

$

1,096,165

$

1,116,298

Total investment retu- annualized

(4.3)%

16.5 %

4.9 %

6.5 %

  1. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

1

Financial Highlights - Per Share Data & ROE

Three months ended

Year ended

December 31,

December 31,

December 31,

December 31,

2024

2023

2024

2023

Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share -

$

(3.95)

$

30.51

$

35.31

$

52.40

basic

Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share -

$

(3.95)

$

30.43

$

35.21

$

52.27

diluted

Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common

$

8.06

$

11.77

$

42.99

$

37.54

share - diluted (1)

Average shares outstanding - basic

50,429

50,937

51,186

47,493

Average shares outstanding - diluted

50,429

51,072

51,339

47,607

Retuon average common equity - annualized

(7.8)%

83.5 %

19.3 %

40.5 %

Operating retuon average common equity - annualized (1)

16.0 %

33.0 %

23.5 %

29.3 %

December 31,

December 31,

2024

2023

Book value per common share

$

195.77

$

165.20

Tangible book value per common share (1)

$

177.18

$

141.87

Tangible book value per common share plus accumulated dividends (1)

$

205.26

$

168.39

Year to date change in book value per common share plus change in accumulated dividends

19.4 %

59.3 %

Year to date change in tangible book value per common share plus change in accumulated dividends (1)

26.0 %

47.6 %

  1. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

2

Summary Consolidated Financial Statements

Consolidated Statements of Operations

Three months ended

Year ended

December 31,

December 31,

December 31,

December 31,

Revenues

2024

2023

2024

2023

Gross premiums written

$

1,916,751

$1,802,041

$11,733,066

$8,862,366

Net premiums written

$

1,751,628

$1,587,047

$9,952,216

$7,467,813

Decrease (increase) in unearned premiums

775,938

662,398

143,544

3,320

Net premiums earned

2,527,566

2,249,445

10,095,760

7,471,133

Net investment income

428,810

376,962

1,654,289

1,253,110

Net foreign exchange gains (losses)

(48,382)

12,398

(76,076)

(41,479)

Equity in earnings (losses) of other ventures

14,652

15,402

47,087

43,474

Other income (loss)

1,129

144

1,928

(6,152)

Net realized and unrealized gains (losses) on investments

(630,347)

585,939

(27,840)

414,522

Total revenues

2,293,428

3,240,290

11,695,148

9,134,608

Expenses

Net claims and claim expenses incurred

1,483,742

979,522

5,332,981

3,573,509

Acquisition expenses

678,170

594,487

2,643,867

1,875,034

Operational expenses

157,104

134,466

496,588

375,182

Corporate expenses

34,295

74,285

134,784

127,642

Interest expense

23,246

23,201

93,768

73,181

Total expenses

2,376,557

1,805,961

8,701,988

6,024,548

Income (loss) before taxes

(83,129)

1,434,329

2,993,160

3,110,060

Income tax benefit (expense)

63,908

554,206

(32,628)

510,067

Net income (loss)

(19,221)

1,988,535

2,960,532

3,620,127

Net (income) loss attributable to redeemable noncontrolling interests

(170,438)

(403,009)

(1,090,172)

(1,058,995)

Net income (loss) attributable to RenaissanceRe

(189,659)

1,585,526

1,870,360

2,561,132

Dividends on preference shares

(8,844)

(8,844)

(35,375)

(35,375)

Net income (loss) available (attributable) to RenaissanceRe common shareholders

$

(198,503)

$1,576,682

$1,834,985

$2,525,757

3

Summary Consolidated Financial Statements

Consolidated Balance Sheets

December 31,

December 31,

Assets

2024

2023

Fixed maturity investments trading, at fair value - amortized cost $23,750,540 at December 31, 2024 (December 31, 2023 - $20,872,450)

$

23,562,514

$

20,877,108

Short term investments, at fair value - amortized cost $4,532,166 at December 31, 2024 (December 31, 2023 - $4,603,340)

4,531,655

4,604,079

Equity investments, at fair value

117,756

106,766

Other investments, at fair value

4,324,761

3,515,566

Investments in other ventures, under equity method

102,770

112,624

Total investments

32,639,456

29,216,143

Cash and cash equivalents

1,676,604

1,877,518

Premiums receivable

7,290,228

7,280,682

Prepaid reinsurance premiums

888,332

924,777

Reinsurance recoverable

4,481,390

5,344,286

Accrued investment income

238,290

205,713

Deferred acquisition costs and value of business acquired

1,552,359

1,751,437

Deferred tax asset

701,053

685,040

Receivable for investments sold

91,669

622,197

Other assets

444,037

323,960

Goodwill and other intangibles

704,132

775,352

Total assets

$

50,707,550

$

49,007,105

Liabilities, Noncontrolling Interests and Shareholders' Equity

Liabilities

Reserve for claims and claim expenses

$

21,303,491

$

20,486,869

Unearned premiums

5,950,415

6,136,135

Debt

1,886,689

1,958,655

Reinsurance balances payable

2,804,344

3,186,174

Payable for investments purchased

150,721

661,611

Other liabilities

1,060,129

1,021,872

Total liabilities

33,155,789

33,451,316

Redeemable noncontrolling interests

6,977,749

6,100,831

Shareholders' Equity

Preference shares: $1.00 par value - 30,000 shares issued and outstanding at December 31, 2024 (December 31, 2023 - 30,000)

750,000

750,000

Common shares: $1.00 par value - 50,180,987 shares issued and outstanding at December 31, 2024 (December 31, 2023 - 52,693,887)

50,181

52,694

Additional paid-in capital

1,512,435

2,144,459

Accumulated other comprehensive loss

(14,756)

(14,211)

Retained earnings

8,276,152

6,522,016

Total shareholders' equity attributable to RenaissanceRe

10,574,012

9,454,958

Total liabilities, noncontrolling interests and shareholders' equity

$

50,707,550

$

49,007,105

Book value per common share

$

195.77

$

165.20

4

Underwriting and Reserves

Consolidated Segment Underwriting Results

Three months ended December 31, 2024

Three months ended December 31, 2023

Property

Casualty and

Total

Property

Casualty and

Total

Specialty

Specialty

Gross premiums written

$

390,043

$

1,526,708

$

1,916,751

$

344,597

$

1,457,444

$

1,802,041

Net premiums written

$

376,136

$

1,375,492

$

1,751,628

$

357,953

$

1,229,094

$

1,587,047

Net premiums earned

$

938,658

$

1,588,908

$

2,527,566

$

884,321

$

1,365,124

$

2,249,445

Net claims and claim expenses incurred

384,156

1,099,586

1,483,742

123,942

855,580

979,522

Acquisition expenses

191,988

486,182

678,170

170,854

423,633

594,487

Operational expenses

95,623

61,481

157,104

85,919

48,547

134,466

Underwriting income (loss)

$

266,891

$

(58,341)

$

208,550

$

503,606

$

37,364

$

540,970

Net claims and claim expenses incurred:

Current accident year

$

732,207

$

1,105,011

$

1,837,218

$

275,638

$

859,694

$

1,135,332

Prior accident years

(348,051)

(5,425)

(353,476)

(151,696)

(4,114)

(155,810)

Total

$

384,156

$

1,099,586

$

1,483,742

$

123,942

$

855,580

$

979,522

Net claims and claim expense ratio:

Current accident year

78.0 %

69.5 %

72.7 %

31.2 %

63.0 %

50.5 %

Prior accident years

(37.1)%

(0.3)%

(14.0)%

(17.2)%

(0.3)%

(7.0)%

Calendar year

40.9 %

69.2 %

58.7 %

14.0 %

62.7 %

43.5 %

Acquisition expense ratio

20.5 %

30.6 %

26.8 %

19.4 %

31.0 %

26.5 %

Operating expense ratio

10.2 %

3.9 %

6.2 %

9.7 %

3.6 %

6.0 %

Combined ratio

71.6 %

103.7 %

91.7 %

43.1 %

97.3 %

76.0 %

Adjusted combined ratio (1)

69.2 %

101.3 %

89.4 %

41.7 %

94.3 %

73.6 %

  1. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

5

Underwriting and Reserves

Consolidated Segment Underwriting Results

Year ended December 31, 2024

Year ended December 31, 2023

Property

Casualty and

Total

Property

Casualty and

Total

Specialty

Specialty

Gross premiums written

$4,823,731

$

6,909,335

$11,733,066

$

3,562,414

$

5,299,952

$8,862,366

Net premiums written

$3,833,636

$

6,118,580

$9,952,216

$

2,967,309

$

4,500,504

$7,467,813

Net premiums earned

$3,850,352

$

6,245,408

$10,095,760

$

3,090,792

$

4,380,341

$7,471,133

Net claims and claim expenses incurred

1,141,726

4,191,255

5,332,981

799,905

2,773,604

3,573,509

Acquisition expenses

758,554

1,885,313

2,643,867

600,127

1,274,907

1,875,034

Operational expenses

302,360

194,228

496,588

251,433

123,749

375,182

Underwriting income (loss)

$1,647,712

$

(25,388)

$1,622,324

$

1,439,327

$

208,081

$1,647,408

Net claims and claim expenses incurred:

Current accident year

$1,960,578

$

4,223,737

$6,184,315

$

1,208,810

$

2,815,306

$4,024,116

Prior accident years

(818,852)

(32,482)

(851,334)

(408,905)

(41,702)

(450,607)

Total

$1,141,726

$

4,191,255

$5,332,981

$

799,905

$

2,773,604

$3,573,509

Net claims and claim expense ratio:

Current accident year

50.9 %

67.6 %

61.3 %

39.1 %

64.3 %

53.9 %

Prior accident years

(21.2)%

(0.5)%

(8.5)%

(13.2)%

(1.0)%

(6.1)%

Calendar year

29.7 %

67.1 %

52.8 %

25.9 %

63.3 %

47.8 %

Acquisition expense ratio

19.6 %

30.2 %

26.2 %

19.4 %

29.1 %

25.1 %

Operating expense ratio

7.9 %

3.1 %

4.9 %

8.1 %

2.8 %

5.0 %

Combined ratio

57.2 %

100.4 %

83.9 %

53.4 %

95.2 %

77.9 %

Adjusted combined ratio (1)

54.9 %

98.0 %

81.5 %

52.9 %

94.2 %

77.1 %

  1. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

6

Attachments

  • Original document
  • Permalink

Disclaimer

RenaissanceRe Holdings Ltd. published this content on January 28, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on January 28, 2025 at 21:25:32.680.

Older

KKR to Present at the Bank of America Securities 2025 Financial Services Conference

Newer

Fourth Quarter 2024 Press Release

Advisor News

  • Todd Buchanan named president of AmeriLife Wealth
  • CFP Board reports record growth in professionals and exam candidates
  • GRASSLEY: WORKING FAMILIES TAX CUTS LAW SUPPORTS IOWA'S FAMILIES, FARMERS AND MORE
  • Retirement Reimagined: This generation says it’s no time to slow down
  • The Conversation Gap: Clients tuning out on advisor health care discussions
More Advisor News

Annuity News

  • Great-West Life & Annuity Insurance Company Trademark Application for “EMPOWER READY SELECT” Filed: Great-West Life & Annuity Insurance Company
  • Retirees drive demand for pension-like income amid $4T savings gap
  • Reframing lifetime income as an essential part of retirement planning
  • Integrity adds further scale with blockbuster acquisition of AIMCOR
  • MetLife Declares First Quarter 2026 Common Stock Dividend
More Annuity News

Health/Employee Benefits News

  • Harshbarger hopes bill will reduce red tape for those with a terminal illness
  • Uninterrupted coverage for thousands as Graves Gilbert, Humana announce new contract
  • Unholy alliance of Democrats, insurers has ruined the system
  • Trump releases health plan, but it’s short on specifics
  • New Findings from University of Colorado in Managed Care and Specialty Pharmacy Provides New Insights (Primary Care Physicians Prescribe Fewer Expensive Combination Medications Than Dermatologists for Acne: a Retrospective Review): Drugs and Therapies – Managed Care and Specialty Pharmacy
More Health/Employee Benefits News

Life Insurance News

  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on India’s Non-Life Insurance Segment
  • AM Best Affirms Credit Ratings of Health Care Service Corporation Group Members and Health Care Service Corp Medicare & Supplemental Group Members
  • Kyle Busch hits PacLife role in amended IUL fraud claims suit
  • I sent a letter to President Trump regarding Greg Lindberg
  • ‘Cashing Out’: Film recounts how viatical settlements arose from AIDS crisis
Sponsor
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

ICMG 2026: 3 Days to Transform Your Business
Speed Networking, deal-making, and insights that spark real growth — all in Miami.

Your trusted annuity partner.
Knighthead Life provides dependable annuities that help your clients retire with confidence.

8.25% Cap Guaranteed for the Full Term
Guaranteed cap rate for 5 & 7 years—no annual resets. Explore Oceanview CapLock FIA.

Press Releases

  • Agent Review Announces Major AI & AIO Platform Enhancements for Consumer Trust and Agent Discovery
  • Prosperity Life Group® Names Industry Veteran Mark Williams VP, National Accounts
  • Salt Financial Announces Collaboration with FTSE Russell on Risk-Managed Index Solutions
  • RFP #T02425
  • RFP #T02525
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet